Benitec Biopharma (BNTC) Operating Leases (2019 - 2025)
Benitec Biopharma (BNTC) reported Operating Leases of $519000.0 for Q4 2025, up 278.83% on a YoY basis from $137000.0 in Q4 2024, and up 28.78% sequentially from $403000.0 in Q3 2025.
Benitec Biopharma (BNTC) Operating Leases (2019 - 2025) Analysis & Trends
Benitec Biopharma (BNTC) has 7 years of Operating Leases data on file, last reported at $519000.0 in Q4 2025.
- For the quarter ending Q4 2025, Operating Leases rose 278.83% year-over-year to $519000.0; the trailing twelve-month figure through Dec 2025 stood at $519000.0 (up 278.83% YoY), and the FY2025 full-year result was $495000.0, changed N/A from the prior year.
- Operating Leases rose to $519000.0 in Q4 2025, from $403000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $954000.0 in Q3 2021 to a low of $54000.0 in Q1 2021.
- A 5-year average of $449157.9 and a median of $422000.0 in 2022 frame the typical range for Operating Leases.
- Across the five-year window, Operating Leases soared 1075.93% in 2022 and plunged 67.54% in 2023, its largest moves.
- Tracing BNTC's Operating Leases over 5 years: stood at $698000.0 in 2021, then tumbled by 39.54% to $422000.0 in 2022, then tumbled by 67.54% to $137000.0 in 2023, then changed by 0.0% to $137000.0 in 2024, then jumped by 278.83% to $519000.0 in 2025.
- Business Quant data shows BNTC's Operating Leases at $519000.0 in Q4 2025, $403000.0 in Q3 2025, and $495000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Benitec Biopharma | 46.45 Mn | 46.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 519,000.00 |
| Sep 30, 2025 | 403,000.00 |
| Jun 30, 2025 | 495,000.00 |
| Mar 31, 2025 | 613,000.00 |
| Dec 31, 2024 | 137,000.00 |
| Sep 30, 2024 | 211,000.00 |
| Mar 31, 2024 | 354,000.00 |
| Dec 31, 2023 | 137,000.00 |
| Sep 30, 2023 | 491,000.00 |
| Jun 30, 2023 | 284,000.00 |
| Mar 31, 2023 | 354,000.00 |
| Dec 31, 2022 | 422,000.00 |
| Sep 30, 2022 | 749,000.00 |
| Jun 30, 2022 | 811,000.00 |
| Mar 31, 2022 | 635,000.00 |
| Dec 31, 2021 | 698,000.00 |
| Sep 30, 2021 | 954,000.00 |
| Jun 30, 2021 | 213,000.00 |
| Mar 31, 2021 | 54,000.00 |
| Dec 31, 2020 | 108,000.00 |